Related references
Note: Only part of the references are listed.Expression and function of the luteinizing hormone choriogonadotropin receptor in human endometrial stromal cells
O. N. Mann et al.
SCIENTIFIC REPORTS (2022)
Nuclear receptors: Key regulators of somatic cell functions in the ovulatory process
Camilla H. K. Hughes et al.
MOLECULAR ASPECTS OF MEDICINE (2021)
Blocking estrogen-induced AMH expression is crucial for normal follicle formation
Ren Tanimoto et al.
DEVELOPMENT (2021)
What Does Unexpected Suboptimal Response During Ovarian Stimulation Suggest, an Overlooked Group?
Bijun Wang et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Revisiting the Impact of Local Leptin Signaling in Folliculogenesis and Oocyte Maturation in Obese Mothers
Karolina Wolodko et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
Alessandro Conforti et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Recombinant luteinizing hormone supplementation to recombinant follicle stimulating hormone therapy in gonadotropin releasing hormone analogue cycles: what is the evidence?
Johnny S. Younis et al.
CURRENT MEDICAL RESEARCH AND OPINION (2018)
When is recombinant luteinizing hormone supplementation beneficial during ovarian stimulation?
Jacqueline Y. Maher et al.
FERTILITY AND STERILITY (2018)
Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review
Carlo Alviggi et al.
FERTILITY AND STERILITY (2018)
Assessment of human embryo development using morphological criteria in an era of time-lapse, algorithms and 'OMICS': is looking good still important?
David K. Gardner et al.
MOLECULAR HUMAN REPRODUCTION (2016)
Progesterone-to-follicle index is better correlated with in vitro fertilization cycle outcome than blood progesterone level
Yoel Shufaro et al.
FERTILITY AND STERILITY (2015)
The sub-optimal response to controlled ovarian stimulation: manageable or inevitable?
F. J. Broekmans
HUMAN REPRODUCTION (2015)
The evaluation of recombinant LH supplementation in patients with suboptimal response to recombinant FSH undergoing IVF treatment with GnRH agonist down-regulation
Fatma Yazici Yilmaz et al.
GYNECOLOGICAL ENDOCRINOLOGY (2015)
Use of clomiphene citrate in infertile women: a committee opinion
Samantha Pfeifer et al.
FERTILITY AND STERILITY (2013)
Too much of a good thing? Experimental evidence suggests prolonged exposure to hCG is detrimental to endometrial receptivity
Jemma Evans et al.
HUMAN REPRODUCTION (2013)
The effect of body mass index on the outcomes of first assisted reproductive technology cycles
Vasiliki A. Moragianni et al.
FERTILITY AND STERILITY (2012)
Overweight and obesity negatively affect the outcomes of ovarian stimulation and in vitro fertilisation: a cohort study of 2628 Chinese women
Dan Zhang et al.
GYNECOLOGICAL ENDOCRINOLOGY (2010)
FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF/ICSI-ET programs
Dimitris Loutradis et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2006)
Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation
G De Placido et al.
CLINICAL ENDOCRINOLOGY (2004)
Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques
AP Ferraretti et al.
FERTILITY AND STERILITY (2004)
Progesterone serum levels during the follicular phase of the menstrual cycle originate from the crosstalk between the ovaries and the adrenal cortex
C De Geyter et al.
HUMAN REPRODUCTION (2002)
Share Paper
